# Probiotics for Abemaciclib-Induced Abdominal Discomfort.

Source: https://onco.cc/trials/nct07605728/  
OnCo record `nct07605728` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of an investigational treatment in advanced solid tumours, run by Leeuwenhoek Laboratories Co. Ltd., now recruiting.

## Summary

Probiotics for Abemaciclib-Induced Abdominal Discomfort. is a phase 2 interventional study registered as NCT07605728 by Leeuwenhoek Laboratories Co. Ltd., with 80 participants planned, started 2026-05-15 and due to reach its primary completion in 2029-06-30.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07605728
- Phase: 2
- Setting: A Randomized, Phase II Study About Probiotics to Alleviate Abemaciclib-induced Abdominal Discomfort Under Standard Anti-diarrhea Drug Loperamide and Changes of Metabolic Factors in Blood.
- Sponsor: Leeuwenhoek Laboratories Co. Ltd.
- Enrolled: 80

## Sources

- ClinicalTrials.gov NCT07605728: https://clinicaltrials.gov/study/NCT07605728

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct07605728.json